These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7911418)

  • 1. Physician estimation of FEV1 in acute exacerbation of COPD.
    Emerman CL; Lukens TW; Effron D
    Chest; 1994 Jun; 105(6):1709-12. PubMed ID: 7911418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease.
    Emerman CL; Cydulka RK
    Ann Emerg Med; 1996 Feb; 27(2):159-63. PubMed ID: 8629745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups.
    Overbeek SE; Kerstjens HA; Bogaard JM; Mulder PG; Postma DS
    Chest; 1996 Jul; 110(1):35-41. PubMed ID: 8681660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction.
    Nava S; Crotti P; Gurrieri G; Fracchia C; Rampulla C
    Chest; 1992 Jan; 101(1):133-40. PubMed ID: 1345900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease.
    Maguire GP; Newman T; DeLorenzo LJ; Brown RB; Stone D
    Chest; 1991 Nov; 100(5):1300-5. PubMed ID: 1935285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD.
    Emerman CL; Effron D; Lukens TW
    Chest; 1991 Mar; 99(3):595-9. PubMed ID: 1995214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung volumes in 4,774 patients with obstructive lung disease.
    Dykstra BJ; Scanlon PD; Kester MM; Beck KC; Enright PL
    Chest; 1999 Jan; 115(1):68-74. PubMed ID: 9925064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician perceptions and management of COPD.
    Kesten S; Chapman KR
    Chest; 1993 Jul; 104(1):254-8. PubMed ID: 8325079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD.
    Boulet LP; Turcotte H; Hudon C; Carrier G; Maltais F
    Can Respir J; 1998; 5(4):270-7. PubMed ID: 9753528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
    Kuhl DA; Agiri OA; Mauro LS
    Ann Pharmacother; 1994 Dec; 28(12):1379-88. PubMed ID: 7696730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does bronchial hyperresponsiveness precede or follow airway obstruction in asthma or COPD?
    van Schayck CP; Dompeling E; Molema J; Folgering H; van Grunsven PM; van Weel C
    Neth J Med; 1994 Oct; 45(4):145-53. PubMed ID: 7808576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
    Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
    N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of lung function in patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease or asthma].
    Lange P; Rasmussen L; Said NM; Ravnholt MM
    Ugeskr Laeger; 2005 Nov; 167(48):4563-6. PubMed ID: 16324438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD?
    Kesten S; Rebuck AS
    Chest; 1994 Apr; 105(4):1042-5. PubMed ID: 8162722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of COPD: factors associated with poor treatment outcome.
    Dewan NA; Rafique S; Kanwar B; Satpathy H; Ryschon K; Tillotson GS; Niederman MS
    Chest; 2000 Mar; 117(3):662-71. PubMed ID: 10712989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD.
    Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.